alexa Nanotechnology in vaccine development: a step forward.
Medicine

Medicine

Journal of Medical Diagnostic Methods

Author(s): Nasir A

Abstract Share this page

Abstract The study of nanotechnology for epicutaneous delivery of pharmaceuticals and vaccines is burgeoning. Topically applied nanomaterials have been shown to enter tape-stripped skin and reach draining lymph nodes in an inbred strain of mice. Nanomaterials in the form of plasmid DNA, proteins, and virus particles accumulate in hair follicles, diffuse via dendritic cells to draining lymph nodes, and elicit antigen-specific humoral and cell-mediated immunity. Topically immunized mice have also demonstrated resistance to infection with live virus. Advantages of nanotechnology include uniformity, reproducibility, and precision in the synthesis and manufacture of candidate compounds. Combined with novel pharmacokinetics and the possibility of targeted therapy, nanotechnology-based vaccines may prove superior to existing vaccines and have the potential to open therapeutic avenues for treating infectious disease and malignancy. This article was published in J Invest Dermatol and referenced in Journal of Medical Diagnostic Methods

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords